SE0104354D0 -
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein
- Google Patents
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein
Info
Publication number
SE0104354D0
SE0104354D0SE0104354ASE0104354ASE0104354D0SE 0104354 D0SE0104354 D0SE 0104354D0SE 0104354 ASE0104354 ASE 0104354ASE 0104354 ASE0104354 ASE 0104354ASE 0104354 D0SE0104354 D0SE 0104354D0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd AbfiledCriticalForskarpatent I Syd Ab
Priority to SE0104354ApriorityCriticalpatent/SE0104354D0/en
Publication of SE0104354D0publicationCriticalpatent/SE0104354D0/en
SE0104354A2001-12-212001-12-21
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein
SE0104354D0
(en)
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein
Peptide-based immunization therapy for the treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density lipoprotein
Neisseira meningitidis serogroup B recombinant lipidated fHbp subfamily A05 protein and Neisseira meningitidis serogroup B recombinant lipidated fHbp subfamily B01 protein
Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based ELISA for determination of immune responses against oxidized low-density lipoprotein